Alfasigma To Acquire Intercept Pharma For $19 Per Share In Cash

Italy's pharma company Alfasigma S.p.A announced on Tuesday that it has signed a definitive agreement to acquire Intercept Pharmaceuticals Inc. (ICPT) for $19.00 per share in cash. The purchase price represents a premium of 82% to Intercept's closing stock price on September 25.